Filing Details

Accession Number:
0001209191-19-042401
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-17 16:52:30
Reporting Period:
2019-07-15
Accepted Time:
2019-07-17 16:52:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1662524 Akcea Therapeutics Inc. AKCA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1629383 Sarah Boyce C/o Akcea Therapeutics, Inc.
22 Boston Wharf Road, 9Th Floor
Boston MA 02210
President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-07-15 1,819 $23.52 19,888 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on April 17, 2018.